Prefer a chat interface with context about you and your work?
Meta-Analysis of Clinical Dose–Response in a Large Drug Development Portfolio
AbstractThis article reports the results of a meta-analysis based on dose–response studies conducted by a large pharmaceutical company between 1998–2009. Data collection targeted efficacy endpoints from all compounds with evidence of clinical efficacy during the time period. Safety data were not extracted. The goal of the meta-analysis was to identify …